MedPage Today - Latest Medical News/Health News Headlines
Latest Headlines News
-
'What You're Seeing Here Is Pure Censorship': What We Heard This Week
(MedPage Today) -- "What you're seeing here is pure censorship." -- Steven Kahn, MBChB, editor-in-chief of Diabetes Care, after American Diabetes Association (ADA) leadership blocked a collection of editorials discussing researchers' removal... -
AMA President: It's Time to Lift Limits on Physician-Owned Hospitals
(MedPage Today) -- Since 2010, the Affordable Care Act (ACA) has expanded health insurance to millions, protecting people with pre-existing conditions and strengthening America's healthcare safety net. But one of its lesser-known provisions has... -
GLP-1s and Alcohol Use Disorder; No Luck With Gonorrhea Vaccine
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical... -
Restrictions on Physician-Owned Hospitals are Justified
(MedPage Today) -- In 2008, The Washington Post reported on a devastating tragedy. A 44-year-old went into respiratory arrest following elective surgery at a physician-owned hospital in Abilene, Texas. The facility, which only provided limited... -
This Year's Ebola Outbreak Has Spread Faster Than the Worst on Record
(MedPage Today) -- The Ebola outbreak in Congo has killed over 1,000 people, reaching the grim milestone nearly three times faster than the 2014-2016 Ebola epidemic that is considered the worst on record.
Data from Congo's Ministry of Health shows... -
Study Links GLP-1s to Lower Risk of Fragility Fractures in Diabetes Patients
(MedPage Today) -- Starting a GLP-1 receptor agonist for type 2 diabetes was associated with a lower risk of fragility fractures in adults 50 and older, including hip and vertebral fractures, according to a large target trial emulation study.... -
Branded Bevacizumab Approved for Wet AMD
(MedPage Today) -- The FDA approved the first formulation of bevacizumab specifically for the treatment of neovascular (wet) age-related macular degeneration (nAMD), Outlook Therapeutics announced on Friday.
The approval of bevacizumab-vikg (Lytenava... -
FDA Panel Finds a Peptide It Doesn't Like
(MedPage Today) -- An FDA panel on Friday continued to recommend loosening compounding restrictions for all but one of the peptides it reviewed, despite safety concerns from agency scientists for all of them.
During the second day of deliberations...